Overactive Bladder Phase II Clinical Trial Results for Encouraging for FP 1097 PA-Based Women's Health Company FemmePharma, Inc.
1/11/2011 8:49:44 AM
More...
|
FemmePharma, Inc. Introduces New Female-Friendly Web Site Created to Educate Women on Breast Health
10/31/2007 1:44:33 PM
More...
|
FemmePharma, Inc. CEO Gerianne Tringali DiPiano Named One of "Pennsylvania’s Best 50 Women in Business"
5/14/2007 2:19:23 PM
More...
|
FemmePharma, Inc. Release: Baltimore Native Returns To Her Roots Seeking Investors And Investigators For New Drug Protocol
5/23/2006 10:55:00 AM
More...
|
FemmePharma Global Healthcare, Inc. Opens Investigational New Drug Application For Treatment Of Breast Pain
3/27/2006 10:54:39 AM
More...
|
FemmePharma, Inc. Creates New Holding Company And Subsidiary
10/19/2005 5:12:24 PM
More...
|
FemmePharma, Inc. Named Company To Watch By Eastern Technology Council
10/19/2005 5:12:11 PM
More...
|
FemmePharma, Inc. CEO To Be Honored At 4th Annual Regional Biotech Council Conference
10/19/2005 5:11:29 PM
More...
|
FemmePharma, Inc. Appoints Ernst & Young As Company's Independent Auditors
10/19/2005 5:11:20 PM
More...
|
FemmePharma, Inc. Presents Phase II Clinical Study Results Of An Investigational Treatment For Endometriosis At The Annual Clinical Meeting Of The American College Of Obstetricians And Gynecologists
10/19/2005 5:11:12 PM
More...
|
|